Safety and effectiveness of amlitelimab, a potential new treatment for atopic dermatitis: results of a clinical trial

被引：0
|
作者：
不详
机构：
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 189卷 / 05期
关键词：
D O I：
10.1093/bjd/ljad357
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E84 / E84
页数：1
相关论文
共 50 条
  • [31] Early treatment of the atopic child: First results of the clinical trial
    Businco, L
    PEDIATRIC PULMONOLOGY, 1997, : 73 - 73
  • [32] A comparative randomized clinical trial evaluating the efficacy and safety of tacrolimus versus hydrocortisone as a topical treatment of atopic dermatitis in children
    Mohamed, Amal A.
    El Borolossy, Radwa
    Salah, Eman M.
    Hussein, Maha S.
    Muharram, Nashwa M.
    Elsalawy, Naglaa
    Khalil, Mona G.
    Mahmoud, Maha O.
    El-Amir, Reham Y.
    Elsanhory, Heba M. A.
    Ahmed, Nourelhuda
    Adaroas, Ahmed S.
    Montaser, Mahmoud
    El Kholy, Amal A.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [33] New oral treatment for atopic dermatitis
    不详
    ARCHIVES OF DISEASE IN CHILDHOOD, 2020, 105 (09) : 847 - 847
  • [34] Evaluation of safety and efficacy of a new cosmetic formulation for treatment of infantile atopic dermatitis
    de Lucas, Raul
    Herranz, Pedro
    Perez-Davo, Azahara
    Vitale, Maria Alejandra
    Redondo, Pedro
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB136 - AB136
  • [35] A new era in the treatment of atopic dermatitis
    Lebwohl, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (04) : 658 - 658
  • [36] Therapeutic Potential of Tralokinumab in the Treatment of Atopic Dermatitis: A Review on the Emerging Clinical Data
    Kelly, Katherine A.
    Perche, Patrick O.
    Feldman, Steven R.
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 : 1037 - 1043
  • [37] Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis
    Loh, Tiffany Y.
    Hsiao, Jennifer L.
    Shi, Vivian Y.
    JOURNAL OF ASTHMA AND ALLERGY, 2020, 13 : 109 - 114
  • [38] Efficacy and Safety of Topical WBI-1001 in the Treatment of Atopic Dermatitis: Results From a Phase 2A, Randomized, Placebo-Controlled Clinical Trial
    Bissonnette, Robert
    Chen, Genhui
    Bolduc, Chantal
    Maari, Catherine
    Lyle, Michael
    Tang, Liren
    Webster, John
    Zhou, Youwen
    ARCHIVES OF DERMATOLOGY, 2010, 146 (04) : 446 - 449
  • [39] The Efficacy and Safety of Abrocitinib as a Treatment Option for Atopic Dermatitis: A Short Report of the Clinical Data
    Napolitano, Maddalena
    Fabbrocini, Gabriella
    Ruggiero, Angelo
    Marino, Vincenzo
    Nocerino, Mariateresa
    Patruno, Cataldo
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 1135 - 1147
  • [40] Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
    Silverberg, Jonathan, I
    Simpson, Eric L.
    Thyssen, Jacob P.
    Gooderham, Melinda
    Chan, Gary
    Feeney, Claire
    Biswas, Pinaki
    Valdez, Hernan
    DiBonaventura, Marco
    Nduaka, Chudy
    Rojo, Ricardo
    JAMA DERMATOLOGY, 2020, 156 (08) : 863 - 873
12345